Goldman Sachs’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History
Bought
Maintained
Sold
Other funds holding OACC
Goldman Sachs's OACC Position: Q3 2026 in Review
Goldman Sachs held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q3 2026 at 529,535 shares worth $5.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3768.
Goldman Sachs first reported a position in OACC in Q1 2025 and has held it in 7 quarters since. 47 funds tracked by Wall St. Rank hold OACC as of Q3 2026.
- Goldman Sachs held 529,535 shares of Oaktree Acquisition Corp III Life Sciences worth $5.69M as of Q3 2026.
- Goldman Sachs left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q3 2026.
- Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #3768 holding.
- Goldman Sachs first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 7 quarters since.
- 47 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.